{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:39:29Z","timestamp":1790995169274,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Mild cases of autonomous aldosterone secretion may go unrecognized using current diagnostic criteria for primary aldosteronism (PA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>To investigate whether the inability to stimulate renin serves as a biomarker for unrecognized autonomous aldosterone secretion and mineralocorticoid receptor (MR) activation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants:<\/jats:title>\n                  <jats:p>Six hundred sixty-three normotensive and mildly hypertensive participants, who were confirmed to not have PA using current guideline criteria and were on no antihypertensive medications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design:<\/jats:title>\n                  <jats:p>Participants had their maximally stimulated plasma renin activity (PRA) measured while standing upright after sodium restriction. Tertiles of maximally stimulated PRA were hypothesized to reflect the degree of MR activation: lowest PRA tertile = \u201cInappropriate\/Excess MR Activity;\u201d middle PRA tertile = \u201cIntermediate MR Activity;\u201d; and highest PRA tertile = \u201cPhysiologic MR Activity.\u201d All participants underwent detailed biochemical and vascular characterizations under conditions of liberalized sodium intake, and associations with stimulated PRA phenotypes were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Participants with lower stimulated PRA had greater autonomous aldosterone secretion [higher aldosterone-to-renin ratio (P = 0.002), higher urine aldosterone excretion rate (P = 0.003), higher systolic blood pressure (P = 0.004), and lower renal plasma flow (P = 0.04)] and a nonsignificant trend toward lower serum potassium and higher urine potassium excretion, which became significant after stratification by hypertension status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>In participants without clinical PA, the inability to stimulate renin was associated with greater autonomous aldosterone secretion, impaired vascular function, and suggestive trends in potassium handling that indicate an extensive spectrum of unrecognized MR activation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2016-3867","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:09:40Z","timestamp":1492614580000},"page":"1835-1843","source":"Crossref","is-referenced-by-count":58,"title":["Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity"],"prefix":"10.1210","volume":"102","author":[{"given":"Gregory L.","family":"Hundemer","sequence":"first","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Baudrand","sequence":"additional","affiliation":[{"name":"Program for Adrenal Disorders and Endocrine Hypertension, Department of Endocrinology, Pontificia Universidad Catolica de Chile School of Medicine, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Curhan","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Williams","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"issue":"5","key":"2020071619461986100_B1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071619461986100_B2","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071619461986100_B3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.25.1.30","article-title":"Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans","volume":"25","author":"Goodfriend","year":"1995","journal-title":"Hypertension"},{"issue":"2","key":"2020071619461986100_B4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.atherosclerosis.2011.09.008","article-title":"Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects","volume":"219","author":"Hannemann","year":"2011","journal-title":"Atherosclerosis"},{"issue":"9","key":"2020071619461986100_B5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"2020071619461986100_B6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.111.00662","article-title":"Abnormal aldosterone physiology and cardiometabolic risk factors","volume":"61","author":"Vaidya","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"2020071619461986100_B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071619461986100_B8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071619461986100_B9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2016.01.003","article-title":"Local control of aldosterone production and primary aldosteronism","volume":"27","author":"Lalli","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"33","key":"2020071619461986100_B10","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2020071619461986100_B11","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071619461986100_B12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.111.173195","article-title":"Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors","volume":"59","author":"Fu","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"2020071619461986100_B13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/physrev.00011.2014","article-title":"Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited","volume":"95","author":"Rossier","year":"2015","journal-title":"Physiol Rev"},{"issue":"10","key":"2020071619461986100_B14","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2012-2127","article-title":"Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus","volume":"97","author":"Underwood","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071619461986100_B15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2265.2010.03922.x","article-title":"The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension","volume":"74","author":"Vaidya","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2020071619461986100_B16","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","article-title":"Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study","volume":"97","author":"Vaidya","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071619461986100_B17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071619461986100_B18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3945\/ajcn.2010.29367","article-title":"Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review","volume":"92","author":"Bernstein","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2020071619461986100_B19","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1681\/ASN.2013121258","article-title":"Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems","volume":"25","author":"Fujita","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2020071619461986100_B20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/1741826710389406","article-title":"Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community","volume":"18","author":"Lieb","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"1","key":"2020071619461986100_B21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/HYPERTENSIONAHA.107.098897","article-title":"Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase","volume":"51","author":"Makhanova","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"2020071619461986100_B22","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071619461986100_B23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"2020071619461986100_B24"},{"issue":"3","key":"2020071619461986100_B25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071619461986100_B26","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6 Pt 2","key":"2020071619461986100_B27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.HYP.15.6.681","article-title":"Differences in blacks and whites with essential hypertension: biochemistry and endocrine. State of the art lecture","volume":"15","author":"Falkner","year":"1990","journal-title":"Hypertension"},{"issue":"6 Pt 2","key":"2020071619461986100_B28","doi-asserted-by":"crossref","first-page":"100S","DOI":"10.1093\/ajh\/3.6.100S","article-title":"Ethnic differences in the renal sodium dopamine relationship. A possible explanation for regional variations in the prevalence of hypertension?","volume":"3","author":"Lee","year":"1990","journal-title":"Am J Hypertens"},{"issue":"10","key":"2020071619461986100_B29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower beta-cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hypertens"},{"issue":"6","key":"2020071619461986100_B30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn\u2019s Registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"issue":"7","key":"2020071619461986100_B31","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071619461986100_B32","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1530\/JME-16-0025","article-title":"Adipocytes, aldosterone and obesity-related hypertension","volume":"57","author":"Dinh Cat","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"2020071619461986100_B33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"2020071619461986100_B34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/HYPERTENSIONAHA.110.168872","article-title":"Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors","volume":"58","author":"Nguyen Dinh Cat","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"2020071619461986100_B35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"issue":"15","key":"2020071619461986100_B36","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"2020071619461986100_B37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am Heart J"},{"issue":"10008","key":"2020071619461986100_B38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"2020071619461986100_B39","article-title":"A continuum of renin-independent aldosteronism in normotension","author":"Baudrand","journal-title":"Hypertension"},{"issue":"4","key":"2020071619461986100_B40","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/6\/1835\/17665186\/jc.2016-3867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/6\/1835\/17665186\/jc.2016-3867.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:47:47Z","timestamp":1594961267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/6\/1835\/3002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3867","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,1]]},"published":{"date-parts":[[2017,2,17]]}}}